Lanosterol biosynthesis
Cholesterol biosynthesis is altered in mice harboring mutations that block peroxisome assembly, suggesting that some steps of lanosterol synthesis might occur in peroxisomes (Faust & Kovacs 2014). These effects could be indirect, however, mediated by cellular ER stress responses to the peroxisome deficiency, consistent with the observation that absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis either in mutant mice or in peroxisome-deficient humans (Hogenboom et al. 2002). All the steps of this pathway have therefore been localized to the cytosol, mediated by cytosolic or ER membrane-associated enzymes.
Statins are a class of medications that lower cholesterol levels in the blood. They work by inhibiting an enzyme called hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, which is involved in the production of cholesterol in the liver.
| UniProt ID | Protein Name | Gene Symbol | Pathway Viewer |
|---|---|---|---|
| P14324 | Farnesyl pyrophosphate synthase |
|
view |
| P53602 | Diphosphomevalonate decarboxylase |
|
view |
| Q01581 | Hydroxymethylglutaryl-CoA synthase, cytoplasmic |
|
view |
| Q03426 | Mevalonate kinase |
|
view |
| Q13907 | Isopentenyl-diphosphate Delta-isomerase 1 |
|
view |
| Q9BWD1 | Acetyl-CoA acetyltransferase, cytosolic |
|
view |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026